ubenimex has been researched along with Ovarian Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H; Feng, J; Xu, W; Yuan, Y; Zhang, J; Zhang, L; Zhang, X | 1 |
| Deng, Y; Fang, C; Mao, S; Qu, M; Shi, L; Wang, X; Xu, L; Xu, W | 1 |
| Cheng, YN; Cui, SX; Gao, JJ; Gao, ZH; Qu, XJ; Tang, W; Xu, WF; Yuan, Y; Zhang, XF; Zhao, CR | 1 |
| Arakawa, H; Fan, X; Ganapathy, V; Nakanishi, T; Ross, DD; Tamai, I | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nawa, A; Shibata, K; Terauchi, M; Yamashita, M | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nawa, A; Shibata, K; Terauchi, M | 1 |
6 other study(ies) available for ubenimex and Ovarian Neoplasms
| Article | Year |
|---|---|
Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Topics: Animals; Antineoplastic Agents; CD13 Antigens; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Female; Inhibitory Concentration 50; Kidney; Leucine; Molecular Docking Simulation; Ovarian Neoplasms; Phenylpropionates; Protease Inhibitors; Structure-Activity Relationship | 2013 |
Inhibition of leucine aminopeptidase 3 suppresses invasion of ovarian cancer cells through down-regulation of fascin and MMP-2/9.
Topics: Carrier Proteins; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Gene Knockdown Techniques; HSP27 Heat-Shock Proteins; Humans; Leucine; Leucyl Aminopeptidase; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microfilament Proteins; Neoplasm Invasiveness; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protease Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2015 |
LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Topics: Animals; CD13 Antigens; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Esters; Female; Humans; Leucine; Mice; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Topics: Aminopeptidases; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Female; Growth Inhibitors; HL-60 Cells; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Ovarian Neoplasms | 2010 |
Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; CD13 Antigens; Cell Line, Tumor; Female; Humans; Leucine; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2007 |
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Topics: Animals; CD13 Antigens; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Humans; Leucine; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Ovarian Neoplasms | 2007 |